Ambulatory blood pressure monitoring: Is it mandatory for blood pressure control in treated hypertensive patients?: Prospective observational study

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2255-2263

  Lehmann, M V ^a   Zeymer, U ^b,c   Dechend, R ^d   Kaiser, E ^e   Hagedorn, I ^e   Deeg, E ^b   Senges, J ^b   Schmieder, R E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

^c KLINIKUM LUDWIGSHAFEN   (Germany)

^d HELIOS KLINIKUM BERLIN BUCH   (Germany)

^e NOVARTIS PHARMA GMBH   (Germany)

Author keywords

Ambulatory blood pressure; Control; Hypertension; Masked hypertension; Treatment

Indexed keywords

ALISKIREN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HEALTH CARE FACILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; WHITE COAT HYPERTENSION; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TIME;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84885602385     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.209     Document Type: Article

References (42)

1. D.L. Clement, M.L. De Buyzere, and D.A. De Bacquer Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension N Engl J Med 348 2003 2407 2415
2. T. Ohkubo, Y. Imai, and I. Tsuji Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama J Hypertens 15 1997 357 364
3. J.A. Staessen, L. Thijs, and R. Fagard Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators JAMA 282 1999 539 546
4. J. Redon, C. Campos, M.L. Narciso, J.L. Rodicio, J.M. Pascual, and L.M. Ruilope Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study Hypertension 31 1998 712 718
5. R.H. Fagard, and H. Celis Prognostic significance of various characteristics of out-of-the-office blood pressure J Hypertens 22 2004 1663 1666
6. K. Bjorklund, L. Lind, B. Zethelius, L. Berglund, and H. Lithell Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men J Hypertens 22 2004 1691 1697
7. K. Kario, A. Lowy, V.C. Munk, and L. Annemans 24-hour blood pressure control-a predictor for clinical outcomes Curr Hypertens Rev 5 2009 102 122
8. R.C. Hermida, D.E. Ayala, A. Mojon, and J.R. Fernandez Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension Am J Hypertens 25 2012 297 305
9. R.C. Hermida, D.E. Ayala, A. Mojon, and J.R. Fernandez Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk J Am Coll Cardiol 58 2011 1165 1173
10. R.C. Hermida, D.E. Ayala, A. Mojon, and J.R. Fernandez Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes Am J Hypertens 25 2012 325 334
11. T. Ohkubo, M. Kikuya, and H. Metoki Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study J Am Coll Cardiol 46 2005 508 515
12. P.H. Gustavsen, A. Hoegholm, L.E. Bang, and K.S. Kristensen White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study J Hum Hypertens 17 2003 811 817
13. S.D. Pierdomenico, D. Lapenna, and A. Bucci Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension Am J Hypertens 18 2005 1422 1428
14. G.A. Head, B.P. McGrath, and A.S. Mihailidou Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement J Hypertens 30 2012 253 266
15. U. Zeymer, R. Dechend, and E. Deeg Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry Int J Clin Pract 66 2012 251 261
16. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
17. G. Mancia, G. De Backer, and A. Dominiczak 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
18. E. Dolan, A. Stanton, and L. Thijs Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study Hypertension 46 2005 156 161
19. T.W. Hansen, J. Jeppesen, S. Rasmussen, H. Ibsen, and C. Torp-Pedersen Ambulatory blood pressure and mortality: a population-based study Hypertension 45 2005 499 504
20. M. Gorostidi, J. Sobrino, and J. Segura Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain J Hypertens 25 2007 977 984
21. P. Palatini, F. Dorigatti, and A. Mugellini Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study Clin Ther 26 2004 1436 1445
22. J.R. Banegas, F.H. Messerli, and B. Waeber Discrepancies between office and ambulatory blood pressure: clinical implications Am J Med 122 2009 1136 1141
23. L.M. Ruilope Current challenges in the clinical management of hypertension Nat Rev Cardiol 9 2011 267 275
24. G. Mancia Defining blood pressure goals: is it enough to manage total cardiovascular risk? J Hypertens Suppl 27 2009 S3 S8
25. G. Parati, L.R. Krakoff, and P. Verdecchia Methods of measurements: home and ambulatory blood pressure monitoring Blood Press Monit 15 2010 100 105
26. T. Krause, K. Lovibond, M. Caulfield, T. McCormack, and B. Williams Management of hypertension: summary of NICE guidance BMJ 343 2011 d4891
27. T. Kabutoya, J. Ishikawa, and S. Hoshide Determinants of negative white-coat effect in treated hypertensive patients: the Jichi Morning Hypertension Research (J-MORE) study Am J Hypertens 22 2009 35 40
28. K. Bjorklund, L. Lind, B. Zethelius, B. Andren, and H. Lithell Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men Circulation 107 2003 1297 1302
29. G. Ogedegbe, C. Agyemang, and J.E. Ravenell Masked hypertension: evidence of the need to treat Curr Hypertens Rep 12 2010 349 355
30. S.D. Pierdomenico, and F. Cuccurullo Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis Am J Hypertens 24 2011 52 58
31. K. Stolarz-Skrzypek, L. Thijs, and B. Wizner From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickering's legacy Blood Press Monit 15 2010 72 81
32. P. Verdecchia, G. Schillaci, F. Boldrini, I. Zampi, and C. Porcellati Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension Hypertension 20 1992 555 562
33. T.G. Pickering, G.D. James, C. Boddie, G.A. Harshfield, S. Blank, and J.H. Laragh How common is white coat hypertension? JAMA 259 1988 225 228
34. G. Mancia, R. Casadei, A. Groppelli, G. Parati, and A. Zanchetti Effect of stress on diagnosis of hypertension Hypertension 17 1991 III56 III62
35. C.M. Ng, S.F. Yiu, K.L. Choi, C.H. Choi, Y.W. Ng, and S.C. Tiu Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics Hong Kong Med J 14 2008 437 443
36. P. Palatini, D. Longo, V. Zaetta, D. Perkovic, R. Garbelotto, and A.C. Pessina Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity J Hypertens 24 2006 1375 1381
37. E. O'Brien, R. Asmar, and L. Beilin European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement J Hypertens 21 2003 821 848
38. T.G. Pickering, K. Eguchi, and K. Kario Masked hypertension: a review Hypertens Res 30 2007 479 488
39. J.P. Baguet, P. Levy, and G. Barone-Rochette Masked hypertension in obstructive sleep apnea syndrome J Hypertens 26 2008 885 892
40. H. Terawaki, H. Metoki, and M. Nakayama Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study Hypertens Res 31 2008 2129 2135
41. K. Yamasue, T. Hayashi, K. Ohshige, O. Tochikubo, and T. Souma Masked hypertension in elderly managerial employees and retirees Clin Exp Hypertens 30 2008 203 211
42. J.E. Sharman, J.L. Hare, and S. Thomas Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise Am J Hypertens 24 2011 898 903